Are Varicose Veins Hereditary? What the Science Shows

"Does it run in families?" is one of the most common questions patients ask when they first notice varicose veins. The short answer is that research points to a genetic contribution. Family history is one of the most consistently reported risk factors for varicose veins in clinical research.

But the relationship between genetics and varicose veins is more nuanced than a simple yes or no. Understanding what the evidence actually shows helps put the question in proper context.

What the Family History Studies Show

The most frequently cited population figures come from European studies examining varicose vein risk stratified by parental history:

• If both parents have varicose veins, the risk in their children has been reported at approximately 89–90%
• If one parent is affected, the risk ranges from approximately 25–62% depending on which parent and the sex of the child
• If neither parent is affected, the risk drops to approximately 20%

These numbers are reported risk estimates, not certainty. But the size of the difference — roughly four to five times the risk when both parents are affected — suggests that inherited factors are an important contributor to varicose vein susceptibility.

Genome-Wide Association Studies: Identifying the Specific Genes

Recent research has moved beyond family history studies to identify specific genetic loci associated with varicose vein risk.

A 2022 study published in Nature Communications (Ahmed et al.) analyzed data from 810,625 individuals and identified 49 signals at 46 genetic loci associated with varicose vein disease. The paper puts heritability at approximately 17%, meaning that roughly one-sixth of the variation in varicose vein susceptibility across the population is attributed to inherited genetic variation.

A study published in Circulation (Fukaya et al., 2018) examined data from 493,519 individuals and identified height as a new independent risk factor: the tallest quarter of participants had a hazard ratio of 1.74 for varicose vein disease compared with the shortest quarter. One proposed explanation is that taller individuals have longer venous columns and therefore a greater hydrostatic pressure load on lower-leg venous valves.

Three Mechanisms: How Genes Influence Venous Disease

1. Extracellular Matrix (ECM) Structural Weakness

Vein walls depend on collagen and elastin networks for mechanical strength. Genetic variants affecting the production or processing of type I and type III collagen, elastin, and matrix metalloproteinases can produce structurally weaker vein walls that dilate more readily under normal venous pressure. Differences in collagen content have been reported in resected varicose vein samples compared to normal vein tissue.

2. Valve Morphology

Venous valve leaflets develop through a distinct genetic program during embryogenesis. Variants in genes regulating valve morphogenesis — including FOXC2 and related transcription factors — have been identified in familial venous disease and may affect the structural integrity of valve leaflets, making them susceptible to earlier incompetence.

3. Inflammatory Susceptibility

Chronic low-grade inflammation plays a role in progressive venous valve dysfunction. Genetic variants affecting inflammatory signaling pathways may predispose to greater vein wall inflammation in response to venous pressure, accelerating the cycle of valve damage and progressive reflux.

Genetic Risk Is Not Destiny

A strong family history of varicose veins does not mean that varicose vein disease is inevitable or untreatable. Genetic risk factors interact with modifiable factors — weight, physical activity, occupational posture, and pregnancy management — in ways that may influence both whether and when venous disease develops.

Understanding your genetic risk is also useful in a practical sense: it is a reason to pay a little more attention to your legs. Patients with a family history who notice symptoms such as heaviness or swelling can have them checked with duplex ultrasound at a consultation; whether and when to treat is then decided from the findings and the symptoms.

---

References: Ahmed et al., Nature Communications 2022; Fukaya et al., Circulation 2018; Shadrina et al., Clinical Genetics 2018; Cornu-Thenard et al., Journal of Dermatologic Surgery 1994